T cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer -induced weakness in the patient's immune system - a weakness that in principle could be...
More... |
All times are GMT -7. The time now is 07:07 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021